Revolutionary, minimally invasive long-term cardiac support device and mitral valve repair technology.
Welcome to Syntach
“Over a million people suffer from severe heart failure and need mechanical circulatory support.”
“Over a million people suffer from severe heart failure and need mechanical circulatory support.”
The Syntach Cardiac Support (CS) Device
Two-thirds of cardiac output is caused by the up and down movement of the mitral valve plane. The Syntach CS Device restores impaired movement of the mitral valve and supports the heart naturally. It is a permanent, active implant that can be inserted with a minimally invasive technique. It is smaller than existing LVAD devices and is therefore suitable for both men and women, as well as people of a smaller build.
Syntach´s products are under development and not approved for clinical use.
The Syntach Cardiac Support (CS) Device
Two-thirds of cardiac output is caused by the up and down movement of the mitral valve plane. The Syntach CS Device restores impaired movement of the mitral valve and supports the heart naturally. It is a permanent, active implant that can be inserted with a minimally invasive technique. It is smaller than existing LVAD devices and is therefore suitable for both men and women, as well as people of a smaller build.
Syntach´s products are under development and not approved for clinical use.
A less invasive procedure, improved quality of life and reduced risk of complications. These are some of the advantages that Prof. Jan Solem saw in his invention, an entirely new approach for supporting the cardiac function in patients with severe heart failure. The technology is applicable to a growing population of more than a million heart failure patients worldwide.
